13F Holdings
中文EN

HLYK HealthLynked Corp

Services-Offices & Clinics of Doctors of Medicine · OTC · SEC CIK 1680139 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-52.0%
TTM net income YoY-4.5%
TTM EPS YoY1.5%
Revenue 3-yr CAGR-43.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-202.3%
Net margin-351.6%
FCF margin—
EBITDA margin-196.7%

Returns

ROE—
ROA-234.0%
ROIC (approx.)—
Asset turnover0.67x

Leverage & solvency

Liabilities / assets641.2%
Debt / equity—
Current ratio0.52x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-153.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.07M$3.01M$5.72M$5.86M$6.50M
SG&A expense$2.04M$3.04M$3.62M$4.58M$4.93M
Operating income-$2.11M-$4.68M-$4.15M-$8.66M-$5.33M
Interest expense——$21,331$0—
Pretax income-$3.28M-$6.13M-$3.61M-$8.07M-$10.70M
Net income-$3.28M-$6.13M-$1.01M-$8.82M-$10.41M
EBITDA-$2.01M-$4.39M-$3.80M-$7.83M-$4.50M
EPS (basic)-1.16-2.180.00-0.04-0.05
EPS (diluted)-1.16-2.180.00-0.04-0.05
Weighted avg. shares (diluted)2.84M2.82M262.89M243.42M224.66M
Balance sheet
Cash & equivalents$37,136$76,241$247,222$61,891$3.29M
Receivables——$20,861$72,284$86,287
Inventory$17,962$44,686$133,222$192,833$134,930
Current assets$1.55M$1.64M$656,160$2.14M$3.65M
PP&E, net$74,705$176,576$290,755$413,123$350,482
Goodwill———$319,958$766,249
Intangibles——$883,848$1.11M$3.81M
Total assets$1.70M$2.22M$4.28M$4.58M$10.69M
Current liabilities$7.01M$4.69M$2.41M$3.47M$1.92M
Short-term debt———$450,000$450,000
Long-term debt———$45,000$101,250
Total debt———$495,000$551,250
Total liabilities$7.46M$5.35M$3.48M$4.27M$3.49M
Shareholders' equity-$5.76M-$3.13M$804,730$314,450$7.20M
Net debt———$433,109-$2.74M
Shares outstanding2.88M2.82M275.96M255.94M237.89M
Cash flow statement
Operating cash flow-$1.71M-$3.49M-$4.14M-$4.36M-$3.77M
Capital expenditure—$2,598$1,500$23,564$19,250
Free cash flow—-$3.50M-$4.15M-$4.39M-$3.79M
Investing cash flow$125,000$422,402$3.51M-$544,750-$341,356
Financing cash flow$1.55M$2.90M$824,087$1.68M$7.24M
Depreciation & amortization$101,871$282,950$352,027$829,481$827,696
Stock-based compensation$158,625$210,333$303,979$100,000—
Share buybacks————$7,700

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.